Behavior change and health-related interventions for heterosexual risk reduction among drug users

Substance Use and Misuse

Volumn 41, Issue 10-12, 2006, Pages 1349-1378

  Semaan, Salaam ^a   Des Jarlais, Don C ^b   Malow, Rob ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Global research; HIV; Injection drug use; Research interventions; Sexual risk

Indexed keywords

ANTIRETROVIRUS AGENT; METHAMPHETAMINE;

BEHAVIOR CHANGE; COMMUNICATION SKILL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DRUG ABUSE; DRUG EFFICACY; DRUG USE; EMERGENCY CARE; EPIDEMIC; FAMILY; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HETEROSEXUALITY; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFECTION PREVENTION; ITALY; NEEDLE; PATIENT COUNSELING; PEER COUNSELING; PEER GROUP; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SAFE SEX; SEX DIFFERENCE; SEX RATIO; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SPAIN; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; COUNSELING; HEALTH BEHAVIOR; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; RISK REDUCTION BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 33749133624     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080600838018     Document Type: Review

References (168)

1. Aceijas, C., Stimson, G. V., Hickman, M., Rhodes, T., on behalf of the United Nations reference group on HIV/AIDS prevention and care among IDU in developing and transitional countries. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303.
2. Amico, K. R., Harman, J. J., Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions. Journal of Acquired Immune Deficiency Syndrome (in press)
3. Andersen, R., Bozzette, S., Shaprio, M., St. Clair,, Morton, S., Crystal, S. (2000). Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Research 35:389-416.
4. Aronowitz, T., Rennells, R. E., Todd, E. (2005). Heterosexual behaviors in early adolescent African American girls: the role of mother-daughter relationships. Journal of Family Nursing 11:122-139.
5. Bachmann, L. H., Lewis, I., Allen, R., Schwebke, J. R., Leviton, L. C., Siegal, H. A., et al. (2000). Risk and prevalence of treatable sexually transmitted diseases at a Birmingham susbtance abuse treatment facility. American Journal of Public Health 90:1615-1618.
6. Bandura, A. (1993). Social cognitive theory and excercise of control over HIV infection. In: Peterson, J. & DiClemente, R., eds. Preventing AIDS: Theory and Practice of Behavioral Interventions. New York: Plenum Press.
7. Bellg, A. J., et al. (2004). Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychology 23:443-451.
8. Beyrer, C., Razak, M. H., Jittiwutikran, J., Suriyanon, V., Vongchak, T., Srirak, N., et al. (2004). Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking susbstance abusers. International Journal of STD & AIDS 15:697-704.
9. Blankenship, K. M., Bray, S. I., Merson, M. H. (2000). Structural interventions in public health. AIDS 14:S11-S21.
10. Bogart, L. M., Catz, S. L., Kelly, J. A., Benotsch, E. G. (2000). Factors influencing physicians' judgements of adherence and treatment decisions for patients with HIV disease. Medical Decision Making 21:28-36.
11. Booth, R., Watters, J. (1994). How effective are risk reduction intervnetions targeting injection drug users?. AIDS 8:1515-1524.
12. Bouhnik, A. D., Moatti, J. P., Vlahov, D., Gallais, H., Dellamonica, P., Obadia, Y., et al. (2002). Highly active antiretroviral treatment does not increase sexual risk behavior among French HIV infected injecting drug users. Journal of Epidemiology and Community Health 56:349-353.
13. Broadhead, R. S., Heckathorn, D. D., Altice, F. L., Hulst, Y., van Carbone, M., Friedland, G. H., et al. (2002). Increasing drug users' adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Social Science and Medicine 55:235-246.
14. Brown, B. S., Beschner, G. M., eds. (1993). Handbook on Risk of AIDS: Injection Drug Users and Their Sexual Partners. Westport, CT: Greenwood Press.
15. Brown, N. L., Luna, V., Ramirez, M. H., Vail, K. A., Williams, C. A. (2005). Developing an effective intervnetion for IDU women: a harm reduction approach to collaboration. AIDS Education and Prevention 17:317-333.
16. Campbell, J. V., Hagan, H., Latka, M. H., Garfein, R. S., Golub, E. T., Coady, M. H., et al. (2005). High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug and Alcohol Dependence
17. Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association 280:544-546.
18. Centers for Disease Control and Prevention. (2003). Advancing HIV prevention: new strategies for a changing epidemic - United States 2003. Morbidity and Mortality Weekly Report 52:329-332.
19. Chakraborty, H., Helms, R. W., Sen, P. K., Cohen, M. S. (2003). Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV-RNA in blood and semen. Statistics in Medicine 15:9-1457.
20. Chakraborty, H., Sen, P. K., Helms, R. W., Vernazza, P. L., Fiscus, C. A., Eron, J. J., et al. (2001). Viral burden in genital secretions determines male-to-female sexual trnasmission of HIV-1: a probabilistic empiric model. AIDS 15:641-643.
21. Chiao, C., Morisky, D., Rosenberg, R., Malow, R. (2006). The relationship between HIV/STI risk and alcohol use during commercial sex episodes: results from the study of female commercial sex workers in the Philippines. Substance Abuse & Misuse, 41:00-00.
22. Cook, R. L., Clark, D. B. (2005). Is there an assocation between alcohol consumption and sexually transmitted diseases? A systematic review. Sexually Transmitted Diseases 32:156-164.
23. Cooper, H., Hedges, L. V. (1994). The Handbook of Research Synthesis. New York: Russell Sage Foundation.
24. Coyle, S. L., Needle, R. H., Normand, J. (1998). Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Reports 113:19-30.
25. Crepaz, N., Hart, T. A., Marks, G. (2004). Highly active antiretroviral therapy and sexual risk behavior. Journal of American Medical Association 292:224-236.
26. Cross, J. E., Saunders, C. M., Bartelli, D. (1998). The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity 32:165-180.
27. Dawson-Rose, C., Shade, S. B., Lum, P. J., Knight, K. R., Parsons, J. T., Purcell, D. W. (2005). Health care experiences of HIV positive injection drug users. Journal of Multicultural Nursing & Health 11:23-30.
28. De Cock, K. M., Marum, E., Mbori-Nagacha, D. (2002). A serostatus-based approach to HIV prevention and care in Africa. Lancet 362:1847-1849.
29. Des Jarlais, D. C. (2000). Structural interventions to reduce HIV transmission among injecting drug users. AIDS 14:S41-S46.
30. Des Jarlais, D. C., Hagan, H., Friedman, S. R., et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 274:1226-1231.
31. Des Jarlais et al. (1995). HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 6:611-617.
32. Des Jarlais, D. C., Marmor, M., Paone, D., et al. (1996). HIV incidence among injecting drug users in New York City syringe exchange programs. Lancet 348:987-991.
33. Des Jarlais, D. C., Wenston, J., Sotheran, J. L., Maslansky, R., Marmor, M. (1992). Crack cocaine use in a cohort of methadone maintenance patients. Journal of Substance Abuse Treatment 9:319-325.
34. Des Jarlais, D. C., Hagan, H., Friedman, S. R. (1997). Epidemiology and emerging public health perspectives. In: Lowinson, J. H., Ruiz, P., Millman, R. B., & Langrod, J. G., eds. Sustance Abuse: A Comprehensive Textbook. Third edition pp. 591-597. Baltimore, MD: Williams and Wilkins.
35. Des Jarlais, D. C., Chamberland, M. E., Yancovitz, S. R., Weinberg, P., Friedman, S. R. (1984). Heterosexual partners: a large risk group for AIDS. Lancet 2:1347.
36. Des Jarlais, D. C., Friedman, S. R., Novick, D. M., Sotheran, J. L., Thomas, P., Yancovitz, S. R. (1989). HIV-1infection among intravenous drug users in Manhattan New York City from 1977 through 1987. JAMA 261:1008-1012.
37. Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Beatrice, S., Milliken, J., et al. (2005). HIV incidence among injection drug users in New York City 1990 to 2002: use of serologic test alogorithm to assess expansion of HIV prevention services. American Journal of Public Health 95:1439-1444.
38. Des Jarlais, D. C., Perlis, T., Firedmann, P., Stimson, G., Poznyak, V. (2004). Issues in HIV prevention for injecting drug users (IDUs) in developing/transitional countries: results from the WHO phase II drug injection study. Paper presented at the Bangkok International AIDS Conference Bangkok, Thailand.
39. Desenclos, J. C., Papaevangelou, G., Ancelle-Park, R. (1993). Knowledge of HIV serostatus and preventive behavior among European injecting drug users. AIDS 7:1371-1377.
40. Elwy, A. R., Hart, G. J., Hawkes, S. (2002). Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men. Archives of Internal Medicine 162:1818-1830.
41. Emerson, C., Brown, T., Illemsky, S., Jean-Jacques, L., Boyles, R., Simpson, G., et al. (2005). Use of social networks to identify persons with undiagnosed HIV infection - Seven U.S. cities October 2003-September 2004. Morbidity and Mortality Weekly Report 54:601-605.
42. Farabee, D., Prendergast, M., Cartier, J. (2002). Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs 34:295-300.
43. Farrell, M., Gowing, L., Marsden, J., Ling, W., Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy 16:67-75.
44. Feist-Price, S., Logan, T. K., Leukefeld, C., Moore, C. L., Ebreo, A. (2003). Targeting HIV prevention on African American crack and injection drug users. Substance Use & Misuse 38:1259-1284.
45. Fournier, A. M., Carmichael, C. (1998). Socioeconomic influences on the transmission of human immunodeficiency virus infection: the hidden risk. Archives of Family Medicine 7:214-217.
46. Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
47. Friedman, S. R., Flom, P. L., Kottiri, B. J., Zenilman, J., Curtis, R., Neaigus, A., et al. (2003a). Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighborhood in New York. Addiction 98:159-169.
48. Friedman, S. R., Kang, S. Y., Deren, S., Robles, R., Colon, H. M., Andia, J., et al. (2002). Drug-scene roles and HIV risk among Puerto rican injection drug users in East Harlem, New York and Baymon, Puerto Rico. Journal of Psychoactive Drugs 34:363-369.
49. Friedman, S. R., Maslow, C., Bolyard, M., Sandoval, M., Mateu-Gelabert, P., Neaigus, A. (2004). Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Education and Prevention 16:250-263.
50. Friedman, S. R., Ompad, D., Maslow, C., et al. (2003b). HIV prevalence social marginalization, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. American Journal of Public Health 93:902-906.
51. Fullilove, R. E., Green, L., Fullilove, M. T. (2000). The family to family program: a structural intervention with implications for the prevention of HIV/AIDS and other community epidemics. AIDS 14:S63-S67.
52. Galea, S., Vlhaov, D. (2002). Social determinants and the health of drug users: socioeconomic status homelessness, and incarceration. Public Health Reports 117:S135-S145.
53. Gebrekristos, H. T., Mlisana, K. P., Karim, Q. A. (2005). Patients' readiness to start highly active antiretroviral treatment for HIV. British Medical Journal 331:772-775.
54. Gibson, D. R., McCusker, J., Chesney, M. (1998). Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users. AIDS 12:919-929.
55. Gordon, C. M., Forsyth, A. D., Stall, R., Cheever, L. W. (2005). Prevention interventions with persons living with HIV/AIDS: state of the science and future directions. AIDS Education and Prevention 17:6-20.
56. Gourevitch, M. N., Hartel, D., Schoenbaum, E. E., Selwyn, P. A., Davenny, K., Friedland, G. H., et al. (1996). A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. American Journal of Public Health 86:1112-1115.
57. Grassly, N. C., Lowndes, C. M., Rhodes, T. (2003). Modeling emerging HIV epidemics: the role of injection drug use and sexual transmission in the Russian Federation, China, and India. International Journal of Drug Policy 14:25-43.
58. Gray, R., Wawer, M., Sewankambo, N., et al. (1999). Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS 13:2113-2123.
59. Greenberg, A. E., Tappero, J., Choopanya, K., VanGriensven, F., Martin, M., Vanichseni, S., et al. (2005). CDC international HIV prevention research activities among IDUs in Thailand and Russia. Journal of Urban Health 82:iv24-iv33.
60. Grosskurth, H. M. F., Todd, J., Mwijarubi, E., Klokke, A., Senkoro, K., Mayaud, P., et al. (1995). Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 346:530-536.
61. Gunn, R. A., Lee, M. A., Callahan, D. B., Gonzales, P., Murray, P. J., Margolis, H. S. (2005). Integrating hepatitis STD and HIV services into a drug rehabilitation program. American Journal of Preventive Medicine 29:27-33.
62. Hamburger, M. E., Moore, J., Koenig, L. J., Vlahov, D., Schoenbaum, E. E., Schuman, P., et al. (2004). Persistence of inconsistent condom use: relation to abuse history and HIV serostatus. AIDS and Behavior 8:333-344.
63. Hedges, L., Veva, J. (1998). Fixed-and random-effects models in meta-analysis. Psychological Methods 3:486-504.
64. Hedges, L. V., Johnson, W. D., Semaan, S., Sogolow, W. (2002). Theoretical issues in the synthesis of HIV prevention research. Journal of Acquired Immune Deficiency Syndrome 30:S8-S14.
65. Hitchcock, P., Fransen, L. (1999). Preventing HIV infection: lessons from Mwanza and Rakai. Lancet 353:513-515.
66. Hwang, L. Y., Ross, M. W., Zack, C., Bull, L., Rickman, K., Holleman, M. (2000). Prevalence of sexually transmitted infections and assoicated risk factors among populations of drug users. Clinical Infectious Diseases 31:920-926.
67. Janssen, R. S., Holtgrave, D. R., Valdiserri, R. O., et al. (2001). The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. American Journal of Public Health 91:1019-1024.
68. Jeanty, Y. J., Metsch, L. R., Wilkinson, J. D., McCoy, C. B. (2003). An investigation of the correlates and predictors of adherence to HIV medication therapy in substance abusing populations. Annual Meeting of the American Public Health Association, abstract 71243.
69. Johnson, W. D., Semaan, S., Hedges, L. V., Ramirez, G., Mullen, P. D., Soglow, E. (2002). A protocol for the analytical aspects of a systematic review of HIV prevention research. Journal of Acquired Immune Deficiency Syndrome 30:S62-S72.
70. Kim, J. C., Watts, C. H. (2005). Gaining a foothold: tackling poverty, gender inequality, and HIV in Africa. British Medical Journal 331:769-772.
71. Knowlton, A. R., Hoover, D. R., Chung, S. E., Celentano, D. D., Vlahov, D., Latkin, C. A. (2001). Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence 64:55-62.
72. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357:1397-1401.
73. Kral, A. H., Lorvick, J., Edlin, B. R. (2000). Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J AIDS 24:162-167.
74. Ksobiech, K. (2003). A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention 15:257-268.
75. Ksobiech, K., Malow, R. (2005). Injection drug use, poverty and HIV among U.S. minorities: the necessity of targeted intervention approaches. Newsletter of addiction division of the American Psychological Association 12:10-12.
76. Kuyper, L. M., Palepu, A., Kerr, T., Kathy, L., Miller, C. L., Spittal, P. M., et al. (2005). Factors associated with sex-trade involvement among female injection drug users in a Canadian setting. Addiction Research and Theory 13:193-199.
77. Lally, M. A., Alvarez, S., Macnevin, R., Cenedella, C., Dispigno, M., Harwell, J. I., et al. (2002). Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sexually Transmitted Diseases 29:752-755.
78. Latka, M., Ahern, J., Garfien, R. S., Ouellet, L., Kerndt, P., Morse, P., et al. (2001). Prevalence incidence and correlates of chlamydia and gonorrhea among young adult injection drug users. Journal of Substance Abuse 13:73-88.
79. Latkin, C. A., Hua, W., Forman, V. L. (2003a). The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, M.D., U.S.A. Internat J STD AIDS 14:770-775.
80. Latkin, C. A., Knowlton, R. A. (2005). Micro-social structural approches to HIV prevention: a social ecological perspective. AIDS Care 17:S102-S113.
81. Latkin, C. A., Mandell, W., Vlahov, D., Oziemkowska, M., Celantano, D. D. (1996). The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the Safe Study. American Journal of Community Psychology 24:341-364.
82. Latkin, C. A., Sherman, S., Knowlton, A. (2003b). HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychology 22:332-339.
83. Latkin, C. A., Williams, C. T., Wang, J., Curry, A. D. (2005). Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychology 24:96-100.
84. Lee, D. M., Binger, A., Hocking, J., Fairley, C. K. (2005). The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalized and regulated system in Melbourne. Sexually Transmitted Infections 81:434-436.
85. Liebschutz, J. M., Finley, E. P., Braslins, P. G., Christiansen, D., Horton, N. J., Samet, J. H. (2003). Screening for sexually transmitted infections in substance abuse treatment programs. Drug and Alcohol Dependence 70:93-99.
86. Logan, T. K., Leukefeld, C. F. D. (1998). Sexual and drug use behaviors among women crack users: implications for prevention. AIDS Education and Prevention 10:327-340.
87. Logan, T. K., Leukefeld, C. (2005). Sexual and drug use behaviors among female crack users: a multi-site sample. Drug and Alcohol Dependence 58:237-245.
88. Lopez-Zetina, J., Ford, W., Weber, M., Barna, S., Woerhle, T., Kerndt, P., et al. (2000). Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County 1994-1996. Sexually Transmitted Infections 76:462-469.
89. Maclachlan, E. W., Baganizi, E., Bougoudogo, F., et al. (2002). The feasibility of integrated sexually transmitted infections prevalence and behavior surveys in eveloping countries. Sexually Transmitted Infections 78:187-189.
90. Malow, R. M., Rosenberg, R., Devieux, J. (2006). Prevention of infection with human immunodeficiency virus in adolescent substance abusers. In: Liddle, H., Rowe, C., eds. Adolescent Substance Abuse: Research and Clinical Advances. Boston: Cambridge Press, pp. 284-309.
91. Malta, M., Carneiro-da-Cunha, C., Kerrigan, D., Strathdee, S. A., Monteiro, M., Bastos, F. L. (2003). Case management of human immunodeficiency virus-infected injection drug users: a case study in Rio de Janeiro, Brazil. Clinical Infectious Diseases 15(Suppl 5):S386.
92. Mansergh, G., Purcell, D. W., Stall, R., McFarlane, M., Semaan, S., Valentine, J., et al. (2006). CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Reports 121:127-132.
93. Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., Shi, J. (2003). A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology 22:223-228.
94. Markos, A. R. (2005). Alcohol and sexual behavior. International Journal of STD and AIDS 16:123-127.
95. Marks, G., Crepaz, N., Senterfitt, J. W., Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 39:446-453.
96. Marx, R., Aral, S. O., Rolfs, R. T. S. C. E., Kahn, J. G. (1991). Crack, sex, and STD. Sexaully Transmitted Diseases 8:92-101.
97. Maslow, C. B., Friedman, S. R., Perlis, T. E., Rockwell, R., Des Jarlais, D. C. (2002). Chagnes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. American Journal of Public Health 92:382-384.
98. Masson, C. L., Sorensen, J. L., Phibbs, C. S., Okin, R. L. (2004). Predictors of medical service utilization among individuals with co-occuring HIV infection and substance abuse disorders. AIDS Care 16:744-755.
99. McArdle, P., Wiegersma, A., Gilvarry, E., et al. (2002). European adolescent substance use: the roles of family, structure fucntion, and gender. Addiction 97:329-336.
100. McCurdy, S. A., Williams, M. L., Ross, M. W., Kilonzo, G. P., Leshabari, M. T. (2005). A theme issue by, for, and about Africa: new injecting practice increases HIV risk among drug users in Tanzania. Bristish Medical Journal 331:778.
101. Metzger, D. S., Navaline, H. (2003). Human immunodeficiency virus prevention and the potential for drug abuse treatment. Clinical Infectious Diseases 37:S451-S456.
102. Mize, S. J. S., Robinson, B. E., Bockting, W. O., Scheltema, K. E. (2002). Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care 14:163-180.
103. Molitor, F., Ruiz, J. D., Flynn, N., Mikanda, J. N., Sun, R. K., Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug & Alcohol Abuse 25:475-493.
104. Needle, R. H., Burrows, D., Friedman, S. R., Dorabjee, J., Touze, G., Badrieva, L., et al. (2005). Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. International Journal of Drug Policy 16S:S45-S57.
105. Needle, R. H., Trotter, R. T., Singer, M., Bates, C., Page, B., Metzger, D., et al. (2003). Rapid assessment of the HIV/AIDS crisis in racial and ethnic minority communities: an approach for timely community interventions. American Journal of Public Health 93:970-979.
106. O'Leary, A., Martins, P. (2000). Structural factors affecting women's HIV risk: a life-course example. AIDS 14:S68-S72.
107. Odutolu, O. (2005). Convergence of behavior change models for AIDS risk reduction in sub-Saharan Africa. International Journal of Health Planning and Management 20:239-252.
108. Ompad, D. C., Ikeda, R. M., Shah, N., Fuller, C. M., Bailey, S., Morse, E., et al. (2005). Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health 95:703-709.
109. Palepu, A., Raj, A., Horton, N. J., Tibbetts, N., Meli, S., Samet, J. H., et al. (2005). Subtsance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. Journal of Substance Abuse Treatment 28:3-9.
110. Panda, S., Chatterjee, A., Battacharya, S. K., Manna, B., Singh, P. N., Sarkar, S., et al. (2000). Transmission of HIV from injecting drug users to their wives in India. International Journal of STD and AIDS 7:468-473.
111. Parish, W. L., Laumann, E. O., Cohen, M. S., et al. (2003). Population-based study of chlamydia infection in China: a hidden epidemic. Journal of the American Medical Association 289:1265-1273.
112. Parker, R. (2002). The global HIV/AIDS pandemic, structural inequalities, and the politics of international health. American Journal of Public Health 92:343-346.
113. Parker, R., Aggleton, P. (2003). HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Social Science and Medicine 57:13-24.
114. Paruk, Z., Petersen, I., Bhana, A., Bell, C., McKay, M. (2005). Containment and contagion: how to strengthen families to support youth HIV prevention in South Africa. African Journal of AIDS Research 4:57-63.
115. Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W. J., Semaan, S., Coyle, S. L., Johnson-Masotti, A. P. (2000). Cost-threshold analyses of the national AIDS demonstration research HIV prevention interventions. AIDS 14:1257-1268.
116. Plitt, S. S., Garfein, R. S., Gaydos, C. A., Strathdee, S. A., Sherman, S. G., Taha, T. E. (2005). Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sexually Transmitted Diseases 32:446-453.
117. Plitt, S. S., Sherman, S. G., Strathdee, S. A., Taha, T. E. (2005). Herpes simplex virus 2 and syphilis among drug users in Baltimore Maryland. Sexually Transmitted Infections 81:248-253.
118. Power, R., Nozhkina, N., Kanarsky, I. (2005). Injecting drug users' experiences of targeted harm reduction in the Russian Federation. Drug and Alcohol Dependence 24:69-77.
119. Prochaska, J. O., Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion 12:38.
120. Pugatch, D. L., Levesque, B. G., Lally, M. A., Reinert, S. E., Filippone, W. J., Combes, C. M., et al. (2001). HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment. J AIDS 27:135-142.
121. Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., Gomez, C. A., Eldred, L., et al. (2004). Interventions for seropositive injectors -research and evaluation (INSPIRE): an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes 37:S118.
122. Quan, V. M., Steketee, R. W., Valleroy, L., Weinstock, H., Karon, J., Janssen, R. (2002). HIV incidence in the United States 1978-1999. J AIDS 31:188-201.
123. Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., Strathdee, S. A. (2005). The social structural production of HIV risk among injection drug users. Social Science and Medicine 61:1026-1044.
124. Robertson, J. R., Bucknall, A. B. V., Welsby, P. D., Roberts, J. J. K., Inglis, J. M., Peutherer, J. F., et al. (1986). Epidemics of AIDS related virus (HTLV-III/LAV) infection among intravenous drug users. Bristish Medical Journal 292:527-529.
125. Ross, M. W., Hwang, L. Y., Leonard, L., Teng, M., Duncan, L. (1999). Sexual behavior, STDs and drug use in a crack house population. International Journal of STD and AIDS 10:224-230.
126. Ross, M. W., Hwang, L. Y., Zack, C., Bull, L., Williams, M. L. (2002). Sexual risk behaviors and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD & AIDS 13:769-774.
127. Rotheram-Borus, M. J., Flannery, D., Rice, E., Lester, P. (2005). Families living with HIV. AIDS Care 17:978-987.
128. Rusch, M. L., Farzadegan, H., Tarwater, P. M., Safaeian, M., Valhov, D., Strathdee, S. A. (2005). Sexual risk behavior among injection drug users before widespeard availability of highly active antiretroviral therapy. AIDS and Behavior 18:1-11.
129. Ryan, C., Semaan, S., Astrat, L. (2003). The interface between sex and drugs: implications for prevention of a generalized epidemic in Vietnam. Presented at the Vietnam MOH and CDC workshop on preventing HIV transmission in injection drug users and other vulnerable populations: a review of evidence-based findings and best practices Hanoi, Vietnam.
130. Saidel, T., Des Jarlais, D. C., Peerapatonapokin, W., et al. (2003). Potential impact of HIV among injection drug users on heterosexual transmission in Asian settings: scenarios from the Asian epidemic model. Journal of Drug Policy 14:63-74.
131. Sangani, P., Rutherford, G., Wilkinson, D. (2004). Population-based interventions for reducing sexually transmitted infections, including HIV infection [review]. Cochrane Database, CDC001220:
132. Semaan, S., Des Jarlais, D., Malow, R. (2006). Sexually transmitted diseases among illicit drug users in the United States: the need for interventions. In: Aral, S. O., Douglas, J., eds. Behavioral Interventions for Prevention and Control of Sexually Transmitted Diseases. New York: Spinger-SBM.
133. Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W., Hedges, L., Ramirez, G., et al. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndrome 30:S73-S93.
134. Semaan, S., Lauby, J., Liebman, J. (2002). Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Review 4:213-223.
135. Semple, S. J., Grant, I., Patterson, T. L. (2005). Negative self-perceptions and sexual risk behavior among heterosexual methamphetamine users. Substance Use & Misuse 40:1797-1810.
136. Semple, S. J., Grant, I., Patterson, T. L. (2004a). Female methamphetamine users: social characteristics and sexual risk behavior. 40:50.
137. Semple, S. J., Patterson, T. L., Grant, I. (2004b). Determinants of condom use stage of change among heterosexually-identified methamphetamine users. AIDS and Behavior 8:391-400.
138. Semple, S. J., Patterson, T. L., Grant, I. (2004c). The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behaviors 29:807-810.
139. Shakarishvili, A., Dubovskaya, L. K., Zohrabyan, L. S., St. Lawrence, J. S., Aral, S. O., Dugasheva, L. G., et al. (2005). Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation. Lancet 366:57-60.
140. Sherman, S. G., German, D., Cheng, Y., Marks, M., Bailey-Kloche, M. (2006). The evaluation of the Jewel project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care 18:1-11.
141. Siegfried, N., Clarke, M., Volmink, J. (2005). Randomized controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. British Medical Journal 331:742.
142. Smith Fawzi, M. C., Lambert, W., Singler, J. M., Koenig, S. P., Leandre, F., Nevil, P., et al. (2003). Prevalence and risk factors of sexually transmitted diseases in rural Haiti: implications for policy and programming in resource-poor settings. International Journal of STD and AIDS 14:848-853.
143. Sogolow, E., Kay, L., Doll, L., et al. (2000). Strengthening HIV prevention: Application of a research to practice framework. AIDS Education and Prevention 12:21-32.
144. Solomon, J., Card, J. J., Malow, R. M. (2006). Adapting efficacious interventions: advancing translational research in HIV prevention. Evaluation and the Health Professions.
145. Sterk, C. E., Theall, K. P., Elifson, K. W. (2002). Health care utilization among drug-using and non-drug-using women. Journal of Urban Health 79:586-599.
146. Sterk, C. E., Theall, K. P., Elifson, K. W. (2003). Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Education and Prevention 15:15-32.
147. Stimson, G., Des Jarlais, D. C., Ball, A. (1998). Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: University College of London Press.
148. Stimson, G. V. H. M., Rhodes, T., Bastos, F., Saidel, T. (2005). Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions. International Journal of Drug Policy.
149. Strathdee, S., Galai, N., Safaeian, M., et al. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine 161:1281-1288.
150. Strathdee, S. A., Palepu, A., Cornelisse, P. G. A., Yip, B. V., O'Shaughnessy, M. V., Montaner, J. S. G., et al. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association 280:547-549.
151. Strathdee, S. A., Sherman, S. G. (2003). The role of sexual transmission of HIV injection and non-injection drug users. Journal of Urban Health 80:iii7-iii14.
152. Sumartojo, E., Doll, L., Holtgrave, D., Gayle, H., Merson, M. (2000). Enriching themix: incorporating the structural factors into HIV prevention. AIDS 14:S1-S2.
153. Thompson, J. C., Kao, T. C., Thomas, R. J. (2005). The relationship between alcohol use and risk-taking sexual behaviors in a large behavioral study. Preventive Medicine 41:247-252.
154. Tran, T. N., Detels, R., Long, H. T., Lan, H. P. (2005). Drug use among female sex workers in Hanoi, Vietnam. Addiction 100:619-625.
155. Tuli, K., Sansom, S., Purcell, D. W., Metsch, L. R., Latkin, C. A., Gourevitch, M. N., et al. (2005). Economic evaluation of an HIV prevention intervention for seropositive injection drug users. Journal of Public Health Management & Practice 11.
156. UNAIDS. (2004). UNAIDS 2004 Report on the Global AIDS Epidemic. Bangkok: UNAIDS.
157. Uuskula, A., Nygard, J. F., Kibur-Nygard, M. (2004). Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & AIDS 15:662-668.
158. van Empelen, P., Kok, G., van Kesteren, N. M. C., ven den Borne, B., Bos,
159. Vlahov, D., Safaien, M., Lai, S., Strathdee, S. A., Johnson, L., Sterling, T., et al. (2001). Sexual and drug risk-related beahviours after initiating highly active antiretroviral therapy among injection drug users. AIDS 15:2311-2316.
160. Ware, N. C., Wyatt, M. A., Tugenberg, T. (2005). Adherence stereotyping and unequal HIV treatment for active users of illegal drugs. Social Science & Medicine 61:565-576.
161. Wendell, D. A., Cohen, D. A., Le Sage, D., Farley, T. A. (2003). Street outreach for HIV prevention: effectiveness of a state-wide programme. International Journal of STD and AIDS 14:334-340.
162. White, R. G., Orroth, K. K., Kornromp, E. L., Bakker, R., Wambura, M., Sewankambo, N. K., et al. (2004). Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials? A modeling study. Journal of Acquired Immune Deficiency Syndrome 37:1500-1513.
163. Williams, M. L., Atkinson, J., Klovdahl, A., Ross, M. W., Timpson, S. (2005). Spatial bridging in a network of drug-using male sex workers. Journal of Urban Health 1:i35-i42.
164. Wodak, A., Cooney, A. (2005). Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy 16S:S31-S44.
165. Wohl, A. R., Johnson, D. F., Lu, S., Jordan, W., Beall, G., Currier, J., et al. (2002). HIV risk behaviors among African American men in Los Angeles County who self identify as heterosexual. Journal of Acquired Immune Deficiency Syndrome 31:354-360.
166. World Health Organization. (2003). Management of Substance Abuse: WHO Drug Injection Study. Geneva, Switzerland: World Health Organization.
167. Young, R. M., Case, P., Friedman, S. R. (2006). Exploring an HIV paradox: an ethnography of sexual minority women injectors. Journal of Lesbian Studies (in press):
168. Young, R. M., Friedman, S. R., Case, P., Asencio, M. W., Clatts, M. (2000). Women injection drug users who have sex with women exhibit increased HIV infection and risk behaviors. Journal of Drug Issues 30:499-524.